Form 4: Tenet Healthcare Director Reports Stock Transactions, Including New RSU Grant and Share Sale

Tenet Healthcare Corp. Director Richard J. Mark reported recent stock transactions, including the acquisition of shares from RSU settlement, a subsequent sale of common stock, and a new grant of restricted stock units.

Summary

• Richard J. Mark, a Director at Tenet Healthcare Corp (THC), reported changes in his beneficial ownership of company securities.
• On May 23, 2025, Mr. Mark acquired 1,551 shares of common stock upon the settlement of previously held restricted stock units (RSUs).
• Concurrently on May 23, 2025, he disposed of 573 shares of common stock at a price of $161.33 per share.
• Following these transactions, Mr. Mark's direct beneficial ownership of common stock stands at 34,281 shares.
• Additionally, on May 22, 2025, Mr. Mark was granted 1,333 new restricted stock units, which are scheduled to vest on May 22, 2026.
• Each restricted stock unit is the economic equivalent of one share of Tenet Healthcare Corp common stock, and the reporting person may elect to receive up to 37% of these new RSUs in cash.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While there was a sale of shares, it appears to be a routine transaction likely related to tax obligations from RSU vesting. The grant of new RSUs to the director is a positive sign of continued alignment with shareholder interests and retention.

Positives

• The grant of 1,333 new Restricted Stock Units (RSUs) to Director Richard J. Mark aligns his long-term interests with the company's performance and shareholder value.
• The acquisition of 1,551 shares from RSU settlement indicates the vesting and conversion of previously awarded equity compensation.

Negatives

• Director Richard J. Mark disposed of 573 shares of common stock at $161.33 per share, which could be for personal liquidity or to cover tax obligations related to the RSU vesting.

Future Outlook

The newly granted 1,333 Restricted Stock Units (RSUs) to Director Richard J. Mark are scheduled to vest on May 22, 2026, indicating future equity compensation realization.

Industry Context

This Form 4 filing represents a routine insider transaction for a director of a publicly traded healthcare company. Such transactions are common for equity compensation plans and personal financial management, and do not inherently reflect broader industry trends.

Stakeholder Impact

• Shareholders: The new RSU grant aligns the director's interests with long-term shareholder value. The sale of shares is a common occurrence for directors managing their equity compensation and tax liabilities, and this specific transaction is not significant enough to materially impact shareholder perception.

Next Steps

• The 1,333 Restricted Stock Units granted on May 22, 2025, are expected to vest on May 22, 2026.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Stock Ownership, Director, Restricted Stock Units, RSU, Common Stock, Equity Compensation